VBI Vaccines Inc. (VBIV)

0.50
0.02 3.08
NASDAQ : Health Technology
Prev Close 0.52
Open 0.53
Day Low/High 0.50 / 0.53
52 Wk Low/High 0.47 / 2.39
Volume 1.83M
Avg Volume 1.78M
Exchange NASDAQ
Shares Outstanding 178.26M
Market Cap 91.52M
EPS -1.00
P/E Ratio N/A
Div & Yield N.A. (N.A)
Does This Under-the-Radar Company Hold the Key to a Zika Vaccine?

Does This Under-the-Radar Company Hold the Key to a Zika Vaccine?

Big pharma is working around the clock to prevent this virus. But here is a small-cap company with loads of potential.

3 Vaccine Manufacturers That Investors Should Consider for Their Portfolios

3 Vaccine Manufacturers That Investors Should Consider for Their Portfolios

Pfizer, Merck and GlaxoSmithKline are all producing blockbuster vaccines and have others in their pipelines.

VBI Vaccines To Present At The World Vaccine Congress Washington

VBI Vaccines To Present At The World Vaccine Congress Washington

New Data Supports the Use of VBI's eVLP Vaccines in Combination with Checkpoint Inhibitors

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of VBI Vaccines Inc. Of An Investigation Concerning The Fairness Of The Sale Of The Company To SciVac Therapeutics Inc. -- VBIV

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of VBI Vaccines Inc. Of An Investigation Concerning The Fairness Of The Sale Of The Company To SciVac Therapeutics Inc. -- VBIV

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased VBI Vaccines Inc.

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of VBI Vaccines Inc. And Encourages Investors To Contact The Firm For Additional Information

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of VBI Vaccines Inc. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of VBI...

VBI SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces The Investigation Of VBI Vaccines Inc. (VBIV) Over The Proposed Sale Of The Company To SciVac Therapeutics Inc.

VBI SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces The Investigation Of VBI Vaccines Inc. (VBIV) Over The Proposed Sale Of The Company To SciVac Therapeutics Inc.

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of VBI Vaccines Inc.

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of VBI Vaccines Inc. And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of VBI Vaccines Inc. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of VBI...

VBI VACCINES INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To SciVac Therapeutics Inc.

VBI VACCINES INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To SciVac Therapeutics Inc.

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of VBI Vaccines Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of VBI Vaccines Inc. Of Commencement Of An Investigation Concerning The Fairness Of The Sale Of The Company To SciVac Therapeutics Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of VBI Vaccines Inc. Of Commencement Of An Investigation Concerning The Fairness Of The Sale Of The Company To SciVac Therapeutics Inc.

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased VBI Vaccines Inc.

TheStreet Quant Rating: D (Sell)